A new nationwide class action lawsuit alleges Kind Patches falsely advertises its GLP-1 patches as increasing natural GLP-1 levels comparable to actual GLP-1 agonist medications like Ozempic.
Plaintiff Maria Alaimo’s class action lawsuit alleges Kind Patches falsely claims that “750k People Are Obsessed with the GLP-1 Patches.”
GLP-1 is a hormone naturally produced by the human body that serves many functions, including slowing digestion, increasing the sensation of satiety after eating, telling the pancreas when to release insulin, and stopping glucose from entering the bloodstream, the Kind Patches class action explains.
Alaimo argues Kind Patches falsely claims its GLP-1 patches are a “Natural Version of Ozempic” that provide a “Stronger GLP-1 Boost” and “Support GLP-1 Production,” despite the fact that the patches do not contain a GLP-1 agonist.
Alaimo alleges Kind Patches falsely claims its product contains “clinically proven ingredients that deliver real results.”
The company also falsely claims the GLP-1 patches are a “[a] smart, cost-effective alternative to expensive injections” that allow users to “skip the injections and discomfort” because “...
In 1995, Princess Diana made broadcasting history and shaped the future of the Royal Family when she sat down with Martin Bashir for an episode of BBC's Panorama. Three decades on, the interview c...